InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Attar Eyal C.. Director active across 2 companies, notably Aprea Therapeutics, Inc.. Aggregated, 23 reports have been logged. Split: 0 buy · 6 sells. Total volume traded: €157k. History available since 25 August 2021. The latest transaction was filed on 13 February 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Attar Eyal C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
2,227 shares@ US$1.425.2% of flowCommon StockSEC:0001415889-25-004406:0
2,554 shares@ US$1.375.8% of flowCommon StockSEC:0001415889-25-003734:0
1,180 shares@ US$1.502.9% of flowCommon StockSEC:0001415889-25-003364:0
1,353 shares@ US$1.343.0% of flowCommon StockSEC:0001415889-25-003173:0
10,334 shares@ US$1.2521.3% of flowCommon StockSEC:0001415889-24-030316:0
999 shares@ US$0.861.3% of flowCommon StockSEC:0001415889-24-026430:0
1,146 shares@ US$0.801.4% of flowCommon StockSEC:0001415889-24-026127:0
999 shares@ US$0.871.4% of flowCommon StockSEC:0001415889-24-020992:0
1,146 shares@ US$0.941.7% of flowCommon StockSEC:0001415889-24-020738:0
14,645 shares@ US$1.3932.1% of flowCommon StockSEC:0001415889-24-015450:0
999 shares@ US$1.752.8% of flowCommon StockSEC:0001415889-24-012460:0
1,146 shares@ US$1.773.2% of flowCommon StockSEC:0001415889-24-012159:0
1,180 shares@ US$2.324.4% of flowCommon StockSEC:0001415889-24-003041:0
62,500 shares0Common StockSEC:0001415889-24-002104:0
999 shares@ US$1.822.9% of flowCommon StockSEC:0001209191-23-054692:0
999 shares@ US$2.674.2% of flowCommon StockSEC:0001209191-23-045181:0
969 shares@ US$4.146.3% of flowCommon StockSEC:0001209191-23-028458:0
54,500 shares0Common StockSEC:0001209191-23-007787:0
32,667 shares@ US$0.80514.0% of flowCommon StockSEC:0001104659-22-068995:0
42,900 shares0Common StockSEC:0001104659-22-033390:0
36,000 shares@ US$1.7332.0% of flowCommon StockSEC:0001104659-22-028757:0
15,968 shares@ US$4.6836.5% of flowCommon StockSEC:0001104659-21-117446:0
9,032 shares@ US$3.9817.5% of flowCommon StockSEC:0001104659-21-110595:0
23 of 23 declarations
About Attar Eyal C.
Attar Eyal C. is a declarant and has 23 filings in total. Across the 23 recent filings tracked, they run from 2021-08-27 to 2025-02-18, with EUR 0 in buys and EUR 156700 in sells, and the most frequent transaction nature is Retenue fiscale. The filings concern Aprea Therapeutics, Inc. and Vor Biopharma Inc., where the stated roles are CHIEF MEDICAL OFFICER and SVP, Chief Medical Officer.
